| Implications for immunosurveillance of altered HLA class I phenotypes in human tumours F Garrido, F Ruiz-Cabello, T Cabrera, JJ Perez-Villar, M López-Botet, ... Immunology today 18 (2), 89-95, 1997 | 1033 | 1997 |
| Natural history of HLA expression during tumour development F Garrido, T Cabrera, A Concha, S Glew, F Ruiz-Cabello, PL Stern Immunology today 14 (10), 491-499, 1993 | 601 | 1993 |
| The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape I Algarra, A García-Lora, T Cabrera, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 53, 904-910, 2004 | 391 | 2004 |
| “Hard” and “soft” lesions underlying the HLA class I alterations in cancer cells: implications for immunotherapy F Garrido, T Cabrera, N Aptsiauri International journal of cancer 127 (2), 249-256, 2010 | 336 | 2010 |
| HLA class I antigen abnormalities and immune escape by malignant cells B Seliger, T Cabrera, F Garrido, S Ferrone Seminars in cancer biology 12 (1), 3-13, 2002 | 330 | 2002 |
| The HLA crossroad in tumor immunology I Algarra, T Cabrera, F Garrido Human immunology 61 (1), 65-73, 2000 | 246 | 2000 |
| High frequency of altered HLA class I phenotypes in invasive breast carcinomas T Cabrera, MA Fernandez, A Sierra, A Garrido, A Herruzo, A Escobedo, ... Human immunology 50 (2), 127-134, 1996 | 211 | 1996 |
| Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: β2‐microglobulin inactivation in MSI‐positive tumors and LMP7/TAP2 … CM Cabrera, P Jimenez, T Cabrera, C Esparza, F Ruiz‐Cabello, ... Tissue antigens 61 (3), 211-219, 2003 | 203 | 2003 |
| Mutations of the β2‐microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides R Benitez, D Godelaine, MA Lopez‐Nevot, F Brasseur, P Jimenez, ... Tissue antigens 52 (6), 520-529, 1998 | 183 | 1998 |
| HLA class I antigens in human tumors F Garrido, T Cabrera, MA Lopez-Nevot, F Ruiz-Cabello Advances in cancer research 67, 155-195, 1995 | 177 | 1995 |
| MHC class I antigens and immune surveillance in transformed cells N Aptsiauri, T Cabrera, A Garcia‐Lora, MA Lopez‐Nevot, F Ruiz‐Cabello, ... International review of cytology 256, 139-189, 2007 | 176 | 2007 |
| Role of altered expression of HLA class I molecules in cancer progression N Aptsiauri, T Cabrera, R Mendez, A Garcia-Lor, F Ruiz-Cabello, ... Immune-Mediated Diseases: From Theory to Therapy, 123-131, 2007 | 174 | 2007 |
| Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy R Carretero, JM Romero, F Ruiz-Cabello, I Maleno, F Rodriguez, ... Immunogenetics 60, 439-447, 2008 | 164 | 2008 |
| Coordinated downregulation of the antigen presentation machinery and HLA class I/β2‐microglobulin complex is responsible for HLA‐ABC loss in bladder cancer JM Romero, P Jiménez, T Cabrera, JM Cózar, S Pedrinaci, M Tallada, ... International journal of cancer 113 (4), 605-610, 2005 | 161 | 2005 |
| Analysis of HLA expression in human tumor tissues T Cabrera, M López-Nevot, J Gaforio, F Ruiz-Cabello, F Garrido Cancer Immunology, Immunotherapy 52, 1-9, 2003 | 156 | 2003 |
| Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors P Jiménez, J Cantón, A Collado, T Cabrera, A Serrano, LM Real, A García, ... International journal of cancer 83 (1), 91-97, 1999 | 146 | 1999 |
| Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome … I Maleno, M López-Nevot, T Cabrera, J Salinero, F Garrido Cancer Immunology, Immunotherapy 51, 389-396, 2002 | 144 | 2002 |
| HLA class II antigen expression in human papillomavirus-associated cervical cancer SS Glew, M Duggan-Keen, T Cabrera, PL Stern Cancer research 52 (14), 4009-4016, 1992 | 140 | 1992 |
| Presence of HPV 16 sequences in laryngeal carcinomas M Perez‐Ayala, F Ruiz‐Cabello, F Esteban, A Concha, M Redondo, ... International journal of cancer 46 (1), 8-11, 1990 | 135 | 1990 |
| Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma M Wölfl, AA Jungbluth, F Garrido, T Cabrera, S Meyen-Southard, R Spitz, ... Cancer Immunology, Immunotherapy 54, 400-406, 2005 | 121 | 2005 |
